Delivery Order SPE2DB22D3501-SPE2DB24FWM30
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,984.84 firm fixed-price contract is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 150ML, a medical product used in healthcare settings. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,690.80, is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.50 firm fixed-price contract is for the delivery of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a medical product used in healthcare settings. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a medical product used for various treatments. The contract has a ceiling value of $1,322.80 and a delivery period through August 28, 2024. It is a firm-fixed-price contract, without any set-aside requirements. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, which is the Corporate Office division of the Amerisourcebergen Corporation. The $4,197.84 firm fixed-price contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract does not have a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,483.60 firm-fixed-price contract is for the supply of OMNIPAQUE 300 MG/ML VIAL 10ML, a medical product, with a performance period ending on May 8, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The award is a firm-fixed-price delivery order with a ceiling value of $3,498.20 and an ultimate completion date of September 25, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,322.80 firm-fixed-price contract is for the supply of Omnipaque 350 mg/ml infusion bottles (100 ml). The contract has an ultimate completion date of January 19, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a medical infusion product. The $2,937.02 firm fixed price contract does not have a set-aside designation and has a total completion date of September 25, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,200.00 firm fixed-price delivery order is for OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of July 1, 2025 and was awarded on June 30, 2025. This award is not set aside. Amerisourcebergen Drug Corp is the prime contractor and holds a $999,999,999.00 Indefinite...